1. Trang chủ
  2. » Giáo Dục - Đào Tạo

interactions of yeasts, moulds, and antifungal agents how to detect resistance

183 603 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 183
Dung lượng 1,07 MB

Nội dung

[...]... efficacious and less toxic triazoles [12] Primary use of ketoconazole is for dermatophyte and Candida superficial skin infections Comments There is little use of ketoconazole outside of treatment of dermatophyte infections, cutaneous Candida infections, and tinea versicolor With the advent of new azoles and echinocandins that offer broader spectrum coverage with lesser toxicity, use of ketoconazole is... Section of Clinical Microbiology, Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH 44195, USA e-mail: hallg@ccf.org J.A Sekeres, Pharm.D • E Neuner, Pharm.D Pharmacy Department, Cleveland Clinic, Cleveland, OH, USA J.O Hall, D.P.M Staff Emeritus, Section of Podiatric Medicine, Cleveland Clinic, Cleveland, OH, USA G.S Hall (ed.), Interactions of Yeasts, Moulds, and Antifungal Agents: How to. .. chromoblastomycosis 1.2.4 Spectrum of Activity The spectrum of activity of 5-FC includes most species of Candida (except for C krusei) and C neoformans and Saccharomyces spp Dematiaceous moulds, responsible for chromoblastomycosis may also be susceptible, such as Phialophora and Cladosporium Aspergillus spp., the Zygomycetes, and dermatophytes are all intrinsically resistant to 5-FC [53] 1 Antifungal Agents. .. Cleveland, OH, USA Audrey Wanger, Ph.D Department of Pathology, University of Texas Medical School, Houston, TX, USA xiii Chapter 1 Antifungal Agents Gerri S Hall, Jennifer A Sekeres, Elizabeth Neuner, and James O Hall Abstract This chapter lists the formulations for and primary uses of, and the mechanisms and spectrum of activity for the major classes of antifungal agents Interpretation of laboratory... outside of treatment of dermatophyte infections, cutaneous Candida infections, and tinea versicolor With the advent of new azoles and echinocandins that offer more broad-spectrum coverage with lesser toxicity, use of miconazole is limited There are, however, more recent studies in the literature advocating miconazole for first-line treatment of oropharyngeal candidiasis [24] 1.3.1.3 Ketoconazole Brand Name/Formulations... of Candida and rare isolates of Cryptococcus neoformans Among the moulds, primary resistance is a characteristic of Aspergillus terreus [7], some species of Fusarium, and members of the Scedosporium genus (including Pseudallescheria boydii) The mechanism for resistance to amphotericin is an alteration in the cell membrane ergosterol that leads to a lowered affinity of the drug due to a lack of appropriate... yeasts and moulds It has indications for use for prophylaxis in patients with risk for serious fungal infections; for empiric therapy in patients who have neutropenia and fever; for treatment of candidiasis including candidal esophagitis and hepatosplenic candidiasis; for severe candidiasis including candidemia, endophthalmitis, and osteomyelitis; and for treatment of aspergillosis, cryptococcosis, and. .. associated with the application of Monistat-Derm Resistance Cross -resistance with other azoles can occur, especially in strains of C glabrata In more recent studies, clinical isolates of Candida spp have been shown to be 1 Antifungal Agents 15 susceptible to miconazole even in isolates that have developed fluconazole resistance and when isolates are exposed to increasing concentrations of miconazole in vitro... compared to conventional amphotericin 1.1.1.4 Spectrum of Activity Amphotericin has a broad spectrum of activity against most yeasts, Aspergillus spp and other hyaline and dematiaceous moulds and systemic dimorphic moulds to include: Candida sp with the possible exception of rare isolates of C lusitaniae [4] Cryptococcus neoformans Aspergillus sp (with exception of A terreus) [7] Other hyaline moulds,. .. cream, tablet, and shampoo available in USA Primary Uses Used for the topical treatment of tinea corporis, tinea cruris, and tinea pedis; treatment of tinea versicolor; treatment of cutaneous candidiasis and seborrheic dermatitis Spectrum of Activity Dermatophyte infections caused by Trichophyton rubrum, T mentagrophytes, and Epidermophyton floccosum; Candida spp.; Malassezia furfur Ketoconazole does . w1 h0" alt="" Interactions of Yeasts, Moulds, and Antifungal Agents Gerri S. Hall Editor Interactions of Yeasts, Moulds, and Antifungal Agents How to Detect Resistance Editor Gerri S. Hall,. Pathology , University of Texas Medical School , Houston , TX , USA Contributors 1 G.S. Hall (ed.), Interactions of Yeasts, Moulds, and Antifungal Agents: How to Detect Resistance, DOI 10.1007/978-1-59745-134-5_1,. designed to cover the topic of antifungal agents and resistance detection in fungal organisms, both yeasts and molds. One chapter is devoted to a description of the most used antifungal agents,

Ngày đăng: 29/05/2014, 16:51

Nguồn tham khảo

Tài liệu tham khảo Loại Chi tiết
11. Pfaller MA, Messer SA, Boyken L et al (2002) In vitro activities of 5-fl uorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrob Agents Chemother 46:3518–3521 Sách, tạp chí
Tiêu đề: Candida
12. Pfaller MA, Messer SA, Hollis RJ et al (2002) In vitro activities of ravuconazole and voricon- azole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob Agents Chemother 46:1723–1727 Sách, tạp chí
Tiêu đề: Candida
13. Pfaller MA, Diekema DJ, Jones RN, The SENTRY Participants Group et al (2002) Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with blood- stream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J Clin Microbiol 40:852–856 Sách, tạp chí
Tiêu đề: Candida
14. Pfaller MA, Messer SA, Boyken L et al (2003) Variation in susceptibility of bloodstream iso- lates of Candida glabrata to fl uconazole according to patient age and geographic location.J Clin Microbiol 41:2176–2179 Sách, tạp chí
Tiêu đề: Candida glabrata
15. Pfaller MA, Diekema DJ (2004) Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus . J Clin Microbiol 42:4419–4431 Sách, tạp chí
Tiêu đề: Candida albicans" and "Aspergillus fumigatus
16. Pfaller MA, Diekema DJ (2004) Twelve years of fl uconazole in clinical practice: global trends in species distribution and fl uconazole susceptibility of bloodstream isolates of Candida . Clin Microbiol Infect 10(suppl 1):11–23 Sách, tạp chí
Tiêu đề: Candida
17. Pfaller MA, Messer SA, Boyken L et al (2004) Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by sue of an international collection of more than 3,000 clinical isolates. J Clin Microbiol 42:3117–3119 Sách, tạp chí
Tiêu đề: Candida
20. Pfaller MA, Messer SA, Boyken L et al (2004) Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. J Clin Microbiol 42:3142–3146 Sách, tạp chí
Tiêu đề: Candida glabrata
21. Pfaller MA, Messer SA, Boyken L, Hollis RJ et al (2004) In vitro activities of voriconazole, posaconazole, and fl uconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. Diagn Microbiol Infect Dis 48:201–205 Sách, tạp chí
Tiêu đề: Candida" spp. and "Cryptococcus "neoformans
22. Pfaller MA, Boyken L, Hollis RJ et al (2005) In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans , and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by Clinical and Laboratory Standards Institute broth microdilu- tion methods. J Clin Microbiol 43:3807–3810 Sách, tạp chí
Tiêu đề: Candida" species, "Cryptococcus neoformans" , and "Aspergillus
23. Pfaller MA, Boyken L, Hollis RJ et al (2005) In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fl uconazole. J Clin Microbiol 43:5425–5427 Sách, tạp chí
Tiêu đề: Candida
24. Pfaller MA, Diekema DJ, Rinaldi MG, The Global Antifungal Surveillance Group et al (2005) Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fl uconazole and voriconazole by stan- dardized disk diffusion testing. J Clin Microbiol 43:5848–5859 Sách, tạp chí
Tiêu đề: Candida
25. Pfaller MA, Boyken L, Messer SA et al (2005) Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS Global Antifungal Surveillance Program. J Clin Microbiol 43:5208–5213 26. Pfaller MA, Boyken L, Hollis RJ et al (2006) In vitro susceptibilities of Candida spp. to caspo-fungin: four years of global surveillance. J Clin Microbiol 44:760–763 Sách, tạp chí
Tiêu đề: Candida" species with results from a central reference laboratory in the ARTEMIS Global Antifungal Surveillance Program. J Clin Microbiol 43:5208–5213 26. Pfaller MA, Boyken L, Hollis RJ et al (2006) In vitro susceptibilities of "Candida
27. Pfaller MA, Diekema DJ, Rex JH et al (2006) Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol 44:819–826 Sách, tạp chí
Tiêu đề: Candida
28. Pfaller MA, Diekema DJ, Sheehan DJ (2006) Interpretive breakpoints for fl uconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev 19:435–447 Sách, tạp chí
Tiêu đề: Candida
29. Pfaller MA, Boyken L, Hollis RJ et al (2006) Global surveillance of the in vitro activity of micafungin against Candida : a comparison with caspofungin using Clinical and Laboratory Standards Institute recommended methods. J Clin Microbiol 44:3533–3538 Sách, tạp chí
Tiêu đề: Candida
31. Pfaller MA, Diekema DJ, Ghannoum A et al (2009) Wild type MIC distribution and epidemio- logic cutoff values for Aspergillus fumigatus and three triazoles as determined by the CLSI broth microdilution methods. J Clin Microbiol 47:3142–3146 Sách, tạp chí
Tiêu đề: Aspergillus fumigatus
38. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG (2007) Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for test- ing amphotericin B, fl ucytosine, and voriconazole against Candida spp. J Clin Microbiol 45:3522–3528 Sách, tạp chí
Tiêu đề: Candida
41. Rex JH, Pfaller MA, Galgiani JN et al (1997) Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro – in vivo cor- relation data for fl uconazole, itraconazole, and Candida infections. Clin Infect Dis 24:235–247 Sách, tạp chí
Tiêu đề: Candida
47. Morrell M, Fraser VJ, Kollef MJ (2005) Delaying empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for mortality.Antimicrob Agents Chemother 49:3640 Sách, tạp chí
Tiêu đề: Candida

TỪ KHÓA LIÊN QUAN

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

w